14 results
PX14A6G
MKT Capital Ltd.
3 May 23
Letter to shareholders
2:53pm
recommended shareholders vote AGAINST Aurinia’s proposal to ratify its NEOs’ compensation due to ‘unmitigated pay-for-performance misalignment
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
2 May 23
Additional proxy soliciting materials
4:39pm
pharmaceutical operations. They also bring strong track records of value creation and commercial success. Aurinia’s executive compensation aligns pay … with performance. Aurinia disagrees with ISS’ recommendation regarding the Company’s advisory vote on executive compensation. Our Compensation
DEFA14A
9vgp9n ox
28 Apr 23
Additional proxy soliciting materials
4:03pm
DEF 14A
0lt29s8z7p
10 May 21
Definitive proxy
4:06pm
PRE 14A
mkd2ska2k8 eylckn5i
27 Apr 21
Preliminary proxy
4:32pm
6-K
EX-99.3
tyq1k f88ms
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
6-K
EX-99.2
cf91t z77m52
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K/A
EX-99.3
w28g14 o1
17 May 18
Current report (foreign) (amended)
12:00am
- Prev
- 1
- Next